The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...